ATLANTA--(BUSINESS WIRE)--Inhibitex, Inc. (NASDAQ:INHX), a biopharmaceutical company focused on developing products to treat and prevent serious infectious diseases, announced that Russell H. Plumb, President and Chief Executive Officer, is scheduled to present an overview of the company and its pipeline of differentiated antiviral compounds at the following three investor conferences in November:
-- 2011 Credit Suisse Healthcare Conference on November 10, 2011 at 10:00 AM MST. The conference is being held at the Arizona Biltmore Resort Hotel & Spa in Phoenix, Arizona.
